![[PDF]](/pb-assets/Icons/adobe-pdf-icon-1498649896243.png){kind=icon}
Abstract
Immune challenges during early development, including those vaccine-induced, can lead to permanent detrimental alterations of the brain and immune function. Experimental evidence also shows that simultaneous administration of as little as two to three immune adjuvants can overcome genetic resistance to autoimmunity. In some developed countries, by the time children are 4 to 6 years old, they will have received a total of 126 antigenic compounds along with high amounts of aluminum (Al) adjuvants through routine vaccinations. According to the US Food and Drug Administration, safety assessments for vaccines have often not included appropriate toxicity studies because vaccines have not been viewed as inherently toxic. Taken together, these observations raise plausible concerns about the overall safety of current childhood vaccination programs. When assessing adjuvant toxicity in children, several key points ought to be considered: (i) infants and children should not be viewed as “small adults” with regard to toxicological risk as their unique physiology makes them much more vulnerable to toxic insults; (ii) in adult humans Al vaccine adjuvants have been linked to a variety of serious autoimmune and inflammatory conditions (i.e., “ASIA”), yet children are regularly exposed to much higher amounts of Al from vaccines than adults; (iii) it is often assumed that peripheral immune responses do not affect brain function. However, it is now clearly established that there is a bidirectional neuro-immune cross-talk that plays crucial roles in immunoregulation as well as brain function. In turn, perturbations of the neuro-immune axis have been demonstrated in many autoimmune diseases encompassed in “ASIA” and are thought to be driven by a hyperactive immune response; and (iv) the same components of the neuro-immune axis that play key roles in brain development and immune function are heavily targeted by Al adjuvants. In summary, research evidence shows that increasing concerns about current vaccination practices may indeed be warranted. Because children may be most at risk of vaccine-induced complications, a rigorous evaluation of the vaccine-related adverse health impacts in the pediatric population is urgently needed.
Keywords
References
| 1. | Bishop, NJ, Morley, R, Day, JP, Lucas, A. Aluminum neurotoxicity in preterm infants receiving intravenous-feeding solutions. N Engl J Med 1997; 336: 1557–1561. Google Scholar | Crossref | Medline | ISI |
| 2. | Wang, M, Chen, JT, Ruan, DY, Xu, YZ. The influence of developmental period of aluminum exposure on synaptic plasticity in the adult rat dentate gyrus in vivo. Neuroscience 2002; 113: 411–419. Google Scholar | Crossref | Medline | ISI |
| 3. | Tomljenovic, L, Shaw, CA. Aluminum Vaccine Adjuvants: Are they Safe? Curr Med Chem 2011; 18: 2630–2637. Google Scholar | Crossref | Medline | ISI |
| 4. | Batista-Duharte, A, Lindblad, EB, Oviedo-Orta, E. Progress in understanding adjuvant immunotoxicity mechanisms. Toxicol Lett 2011; 203: 97–105. Google Scholar | Crossref | Medline | ISI |
| 5. | Israeli, E, Agmon-Levin, N, Blank, M, Shoenfeld, Y. Adjuvants and autoimmunity. Lupus 2009; 18: 1217–1225. Google Scholar | SAGE Journals | ISI |
| 6. | Shoenfeld, Y, Agmon-Levin, N. “ASIA” - Autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun 2011; 36: 4–8. Google Scholar | Crossref | Medline | ISI |
| 7. | Eisenbarth, SC, Colegio, OR, O'Connor, W, Sutterwala, FS, Flavell, RA. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 2008; 453: 1122–1126. Google Scholar | Crossref | Medline | ISI |
| 8. | Exley, C, Siesjo, P, Eriksson, H. The immunobiology of aluminium adjuvants: how do they really work? Trends Immunol 2010; 31: 103–109. Google Scholar | Crossref | Medline | ISI |
| 9. | Eickhoff, TC, Myers, M. Workshop summary. Aluminum in vaccines. Vaccine 2002; 20(Suppl. 3): S1–S4. Google Scholar | Crossref | Medline | ISI |
| 10. | Couette, M, Boisse, MF, Maison, P. Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction. J Inorg Biochem 2009; 103: 1571–1578. Google Scholar | Crossref | Medline | ISI |
| 11. | Dorea, JG, Marques, RC. Infants' exposure to aluminum from vaccines and breast milk during the first 6 months. J Expo Sci Environ Epidemiol 2010; 20: 598–601. Google Scholar | Crossref | Medline | ISI |
| 12. | Agency for toxic substances and disease registry. Toxicological profile for aluminum (2008). http://www.atsdr.cdc.gov/toxprofiles/tp22.html. Google Scholar |
| 13. | Tomljenovic, L . Aluminum, Alzheimer's disease: after a century of controversy, is there a plausible link? J Alzheimers Dis 2011; 23: 567–598. Google Scholar | Crossref | Medline | ISI |
| 14. | Cohen, AD, Shoenfeld, Y. Vaccine-induced autoimmunity. J Autoimmun 1996; 9: 699–703. Google Scholar | Crossref | Medline | ISI |
| 15. | Galic, MA, Riazi, K, Heida, JG. Postnatal inflammation increases seizure susceptibility in adult rats. J Neurosci 2008; 28: 6904–6913. Google Scholar | Crossref | Medline | ISI |
| 16. | Konat, GW, Lally, BE, Toth, AA, Salm, AK. Peripheral immune challenge with viral mimic during early postnatal period robustly enhances anxiety-like behavior in young adult rats. Metab Brain Dis 2011; 26: 237–240. Google Scholar | Crossref | Medline | ISI |
| 17. | Hewitson, L, Houser, LA, Stott, C. Delayed acquisition of neonatal reflexes in newborn primates receiving a thimerosal-containing hepatitis B vaccine: influence of gestational age and birth weight. J Toxicol Environ Health A 2010; 73: 1298–1313. Google Scholar | Crossref | Medline |
| 18. | Tomljenovic L, Shaw CA. Do aluminum vaccine adjuvants contribute to the rising prevalence of autism? J Inorg Biochem 2011, doi:10.1016/j.jinorgbio.2011.08.008. Google Scholar |
| 19. | Besedovsky, HO, Rey, A. Brain cytokines as integrators of the immune–neuroendocrine network. In: Lajtha, A, Besedovsky, HO, Galoyan, A (eds). Handbook of neurochemistry and molecular neurobiology, 3rd edn. London: Springer; 2008. 3–17. Google Scholar | Crossref |
| 20. | Elenkov, IJ, Wilder, RL, Chrousos, GP, Vizi, ES. The sympathetic nerve–an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 2000; 52: 595–638. Google Scholar | Medline | ISI |
| 21. | Neeck, G, Crofford, LJ. Neuroendocrine perturbations in fibromyalgia and chronic fatigue syndrome. Rheum Dis Clin North Am 2000; 26: 989–1002. Google Scholar | Crossref | Medline | ISI |
| 22. | Gutierrez, MA, Garcia, ME, Rodriguez, JA, Rivero, S, Jacobelli, S. Hypothalamic-pituitary-adrenal axis function and prolactin secretion in systemic lupus erythematosus. Lupus 1998; 7: 404–408. Google Scholar | SAGE Journals | ISI |
| 23. | Chikanza, IC, Petrou, P, Kingsley, G, Chrousos, G, Panayi, GS. Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum 1992; 35: 1281–1288. Google Scholar | Crossref | Medline |
| 24. | Michelson, D, Stone, L, Galliven, E. Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function. J Clin Endocrinol Metab 1994; 79: 848–853. Google Scholar | Medline | ISI |
| 25. | Garay, PA, McAllister, AK. Novel roles for immune molecules in neural development: implications for neurodevelopmental disorders. Front Synaptic Neurosci 2010; 2: 136–136. Google Scholar | Crossref | Medline |
| 26. | Rose, NR . Autoimmunity, infection and adjuvants. Lupus 2010; 19: 354–358. Google Scholar | SAGE Journals | ISI |
| 27. | Dillon, SB, Demuth, SG, Schneider, MA. Induction of protective class I MHC-restricted CTL in mice by a recombinant influenza vaccine in aluminium hydroxide adjuvant. Vaccine 1992; 10: 309–318. Google Scholar | Crossref | Medline | ISI |
| 28. | Seubert, A, Monaci, E, Pizza, M, O'Hagan, DT, Wack, A. The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells. J Immunol 2008; 180: 5402–5412. Google Scholar | Crossref | Medline | ISI |
| 29. | Zheng, W . Neurotoxicology of the brain barrier system: new implications. J Toxicol Clin Toxicol 2001; 39: 711–719. Google Scholar | Crossref | Medline | ISI |
| 30. | Siegrist, CA, Aspinall, R. B-cell responses to vaccination at the extremes of age. Nat Rev Immunol 2009; 9: 185–194. Google Scholar | Crossref | Medline | ISI |
| 31. | Siegrist, CA . Neonatal and early life vaccinology. Vaccine 2001; 19: 3331–3346. Google Scholar | Crossref | Medline | ISI |
| 32. | Chelvarajan, L, Popa, D, Liu, Y, Getchell, TV, Stromberg, AJ, Bondada, S. Molecular mechanisms underlying anti-inflammatory phenotype of neonatal splenic macrophages. J Leukoc Biol 2007; 82: 403–416. Google Scholar | Crossref | Medline | ISI |
| 33. | Wilder, RL . Neuroendocrine-immune system interactions and autoimmunity. Annu Rev Immunol 1995; 13: 307–338. Google Scholar | Crossref | Medline | ISI |
| 34. | Eskandari, F, Webster, JI, Sternberg, EM. Neural immune pathways and their connection to inflammatory diseases. Arthritis Res Ther 2003; 5: 251–265. Google Scholar | Crossref | Medline | ISI |
| 35. | Gallagher, CM, Goodman, MS. Hepatitis B vaccination of male neonates and autism diagnosis, NHIS 1997-2002. J Toxicol Environ Health A 2010; 73: 1665–1677. Google Scholar | Crossref | Medline |
| 36. | Poling, JS, Frye, RE, Shoffner, J, Zimmerman, AW. Developmental regression and mitochondrial dysfunction in a child with autism. J Child Neurol 2006; 21: 170–172. Google Scholar | SAGE Journals | ISI |
| 37. | Agmon-Levin, N, Kivity, S, Szyper-Kravitz, M, Shoenfeld, Y. Transverse myelitis and vaccines: a multi-analysis. Lupus 2009; 18: 1198–1204. Google Scholar | SAGE Journals | ISI |
| 38. | Classen, JB . Childhood immunisation and diabetes mellitus. N Z Med J 1996; 109: 195–195. Google Scholar | Medline | ISI |
| 39. | Girard, M . Autoimmune hazards of hepatitis B vaccine. Autoimmun Rev 2005; 4: 96–100. Google Scholar | Crossref | Medline | ISI |
| 40. | Hofmann, C, Baur, MO, Schroten, H. Anti-NMDA receptor encephalitis after TdaP-IPV booster vaccination: cause or coincidence? J Neurol 2010; 258: 500–501. Google Scholar | Crossref | Medline | ISI |
| 41. | Brewer, JM . (How) do aluminium adjuvants work? Immunol Lett 2006; 102: 10–15. Google Scholar | Crossref | Medline | ISI |
| 42. | HogenEsch, H . Mechanisms of stimulation of the immune response by aluminum adjuvants. Vaccine 2002; 20(Suppl. 3): S34–S39. Google Scholar | Crossref | Medline | ISI |
| 43. | Fournie, GJ, Mas, M, Cautain, B. Induction of autoimmunity through bystander effects. Lessons from immunological disorders induced by heavy metals. J Autoimmun 2001; 16: 319–326. Google Scholar | Crossref | Medline | ISI |
| 44. | Agmon-Levin, N, Paz, Z, Israeli, E, Shoenfeld, Y. Vaccines and autoimmunity. Nat Rev Rheumatol 2009; 5: 648–652. Google Scholar | Crossref | Medline | ISI |
| 45. | Tsumiyama, K, Miyazaki, Y, Shiozawa, S. Self-organized criticality theory of autoimmunity. PLoS One 2009; 4: e8382–e8382. Google Scholar | Crossref | Medline | ISI |
| 46. | Food and Drug Administration. Workshop on Non-clinical Safety Evaluation of Preventative Vaccines: Recent Advances and Regulatory Considerations (2002). http://www.fda.gov/downloads/biologicsbloodvaccines/newsevents/workshopsmeetingsconferences/transcriptsminutes/ucm054459.pdf. Google Scholar |
| 47. | Zinka, B, Penning, R. Unexplained cases of sudden infant death shortly after hexavalent vaccination. Letter to Editor. Response to the comment by HJ Schmitt et al. Vaccine 2006; 24: 5785–5786. Google Scholar | Crossref | ISI |
| 48. | Silvers, LE, Ellenberg, SS, Wise, RP, Varricchio, FE, Mootrey, GT, Salive, ME. The epidemiology of fatalities reported to the vaccine adverse event reporting system 1990-1997. Pharmacoepidemiol Drug Saf 2001; 10: 279–285. Google Scholar | Crossref | Medline | ISI |
| 49. | Miravalle, A, Biller, J, Schnitzler, E, Bonwit, A. Neurological complications following vaccinations. Neurol Res 2010; 32: 285–292. Google Scholar | Crossref | Medline | ISI |
| 50. | Exley C. Aluminium-based adjuvants should not be used as placebos in clinical trials. Vaccine 2011; doi:10.1016/j.vaccine.2011.08.062. Google Scholar |
| 51. | Kovel, A, Wald, ER, Guerra, N, Serdy, C, Meschievitz, CK. Safety and immunogenicity of acellular diphtheria-tetanus-pertussis and Haemophilus conjugate vaccines given in combination or at separate injection sites. J Pediatr 1992; 120: 84–87. Google Scholar | Crossref | Medline | ISI |
| 52. | Kaplan, SL, Lauer, BA, Ward, MA. Immunogenicity and safety of Haemophilus influenzae type b-tetanus protein conjugate vaccine alone or mixed with diphtheria-tetanus-pertussis vaccine in infants. J Pediatr 1994; 124: 323–327. Google Scholar | Crossref | Medline | ISI |
| 53. | Velu, V, Nandakumar, S, Shanmugam, S. Comparative efficacy of two dosages of recombinant hepatitis B vaccine in healthy adolescents in India. Pediatr Infect Dis J 2007; 26: 1038–1041. Google Scholar | Crossref | Medline | ISI |
| 54. | Contraindications and precautionary conditions for vaccination from selected authoritative sources, November 2009. http://www. epid.gov.lk/pdf/Immunization/CONTRAINDICATIONS%20AND%20PRECAUTIONARY%20CONDITIONS%20FOR%20VACCINATION.pdf. Google Scholar |
| 55. | Lerner, A . Aluminum is a potential environmental factor for Crohn's disease induction: extended hypothesis. Ann N Y Acad Sci 2007; 1107: 329–345. Google Scholar | Crossref | Medline | ISI |
| 56. | Elenkov, IJ, Chrousos, GP. Stress hormones, Th1/Th2 patterns, pro/anti-inflammatory cytokines and susceptibility to disease. Trends Endocrinol Metab 1999; 10: 359–368. Google Scholar | Crossref | Medline | ISI |
| 57. | Gherardi, RK, Coquet, M, Cherin, P. Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle. Brain 2001; 124: 1821–1831. Google Scholar | Crossref | Medline | ISI |
| 58. | Gherardi, RK . [Lessons from macrophagic myofasciitis: towards definition of a vaccine adjuvant-related syndrome]. Rev Neurol (Paris) 2003; 159: 162–164. Google Scholar | Medline | ISI |
| 59. | Skowera, A, Cleare, A, Blair, D, Bevis, L, Wessely, SC, Peakman, M. High levels of type 2 cytokine-producing cells in chronic fatigue syndrome. Clin Exp Immunol 2004; 135: 294–302. Google Scholar | Crossref | Medline | ISI |
| 60. | Broderick, G, Kreitz, A, Fuite, J, Fletcher, MA, Vernon, SD, Klimas, N. A pilot study of immune network remodeling under challenge in Gulf War Illness. Brain Behav Immun 2010; 25: 302–313. Google Scholar | Crossref | Medline | ISI |
| 61. | Singh, VK . Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism. J Neuroimmunol 1996; 66: 143–145. Google Scholar | Crossref | Medline | ISI |
| 62. | Molloy, CA, Morrow, AL, Meinzen-Derr, J. Elevated cytokine levels in children with autism spectrum disorder. J Neuroimmunol 2006; 172: 198–205. Google Scholar | Crossref | Medline | ISI |
| 63. | del Rey, A, Wolff, C, Wildmann, J. Disrupted brain-immune system-joint communication during experimental arthritis. Arthritis Rheum 2008; 58: 3090–3099. Google Scholar | Crossref | Medline |
| 64. | Jha, S, Srivastava, SY, Brickey, WJ. The inflammasome sensor, NLRP3, regulates CNS inflammation and demyelination via caspase-1 and interleukin-18. J Neurosci 2010; 30: 15811–15820. Google Scholar | Crossref | Medline | ISI |
| 65. | Gris, D, Ye, Z, Iocca, HA. NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses. J Immunol 2010; 185: 974–981. Google Scholar | Crossref | Medline | ISI |
| 66. | Wen, H, Gris, D, Lei, Y. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol 2011; 12: 408–415. Google Scholar | Crossref | Medline | ISI |
| 67. | Bauer, C, Duewell, P, Mayer, C. Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome. Gut 2010; 59: 1192–1199. Google Scholar | Crossref | Medline | ISI |
| 68. | Aringer, M, Smolen, JS. Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: a rationale for therapeutic intervention. Lupus 2004; 13: 344–347. Google Scholar | SAGE Journals | ISI |
| 69. | Exley, C, Swarbrick, L, Gherardi, RK, Authier, FJ. A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome. Med Hypotheses 2009; 72: 135–139. Google Scholar | Crossref | Medline | ISI |
| 70. | Vargas, DL, Nascimbene, C, Krishnan, C, Zimmerman, AW, Pardo, CA. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 2005; 57: 67–81. Google Scholar | Crossref | Medline | ISI |
| 71. | Gupta, S, Aggarwal, S, Rashanravan, B, Lee, T. Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism. J Neuroimmunol 1998; 85: 106–109. Google Scholar | Crossref | Medline | ISI |
| 72. | Pardo, CA, Vargas, DL, Zimmerman, AW. Immunity, neuroglia and neuroinflammation in autism. Int Rev Psychiatry 2005; 17: 485–495. Google Scholar | Crossref | Medline | ISI |
| 73. | Smith, KM, Garside, P, McNeil, RC, Brewer, JM. Analysis of costimulatory molecule expression on antigen-specific T and B cells during the induction of adjuvant-induced Th1 and Th2 type responses. Vaccine 2006; 24: 3035–3043. Google Scholar | Crossref | Medline | ISI |
| 74. | Davis, HL, Weeratna, R, Waldschmidt, TJ, Tygrett, L, Schorr, J, Krieg, AM. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J Immunol 1998; 160: 870–876. Google Scholar | Medline | ISI |
| 75. | Brazolot Millan, CL, Weeratna, R, Krieg, AM, Siegrist, CA, Davis, HL. CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice. Proc Natl Acad Sci U S A 1998; 95: 15553–15558. Google Scholar | Crossref | Medline | ISI |
| 76. | Shaw, CA, Petrik, MS. Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration. J Inorg Biochem 2009; 103: 1555–1562. Google Scholar | Crossref | Medline | ISI |
| 77. | Aron-Maor, A, Shoenfeld, Y. Vaccination and systemic lupus erythematosus: the bidirectional dilemmas. Lupus 2001; 10: 237–240. Google Scholar | SAGE Journals | ISI |
| 78. | Sutton, I, Lahoria, R, Tan, IL, Clouston, P, Barnett, MH. CNS demyelination and quadrivalent HPV vaccination. Mult Scler 2009; 15: 116–119. Google Scholar | SAGE Journals | ISI |
| 79. | Chang, J, Campagnolo, D, Vollmer, TL, Bomprezzi, R. Demyelinating disease and polyvalent human papilloma virus vaccination. J Neurol Neurosurg Psychiatry 2010; 1–3. Google Scholar | Medline | ISI |
| 80. | Centers for Disease Control and Prevention. 2010 Child and Adolescent Immunization Schedules for persons aged 0–6 years, 7–18 years, and “catch-up schedule’ and Past Childhood Immunization Schedules. http://www.cdc.gov/vaccines/recs/schedules/child-schedule.htm#chgs. Google Scholar |
| 81. | Miller, E, Andrews, N, Waight, P. Safety and immunogenicity of co-administering a combined meningococcal serogroup C and Haemophilus influenzae type b conjugate vaccine with 7-valent pneumococcal conjugate vaccine and measles, mumps and rubella vaccine at 12 months of age. Clin Vaccine Immunol 2010; 18: 367–372. Google Scholar | Crossref | Medline | ISI |
| 82. | GlaxoSmithKline. Engerix-B product monograph (2010). http://us.gsk.com/products/assets/us_engerixb.pdf. Google Scholar |
| 83. | Iwarson, S . Strategies for immunization against hepatitis B in western Europe. Vaccine 1993; 11(Suppl. 1): S18–S20. Google Scholar | Crossref | Medline | ISI |
| 84. | Verstraeten, T, Descamps, D, David, MP. Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines. Vaccine 2008; 26: 6630–6638. Google Scholar | Crossref | Medline | ISI |
| 85. | Mendoza Plasencia, Z, Gonzalez Lopez, M, Fernandez Sanfiel, ML, Muniz Montes, JR. [Acute disseminated encephalomyelitis with tumefactive lesions after vaccination against human papillomavirus]. Neurologia 2010; 25: 58–59. Google Scholar | Crossref | Medline | ISI |
| 86. | Das, A, Chang, D, Biankin, AV, Merrett, ND. Pancreatitis following human papillomavirus vaccination. Med J Aust 2008; 189: 178–178. Google Scholar | Crossref | Medline | ISI |
| 87. | Phillips, CJ, Matyas, GR, Hansen, CJ, Alving, CR, Smith, TC, Ryan, MA. Antibodies to squalene in US Navy Persian Gulf War veterans with chronic multisymptom illness. Vaccine 2009; 27: 3921–3926. Google Scholar | Crossref | Medline | ISI |
